Adam Schaffer, MD,* and Sylvia McKean, MD†
Acute renal failure (ARF) is an important and often preventable complication of hospitalization. Patients with even modest increases in their serum creatinine have increases in their mortality, length of stay, and hospital costs. Postoperative ARF represents 9% to 25% of all cases of hospital-acquired renal insufficiency. Risk factors for postoperative ARF can be identified in advance and preventive measures taken to avoid the development of renal insufficiency. The following module explains the roles of medical treatment in lowering the risk of perioperative ARF, the typical presentation of ARF postoperatively, the diagnostic approach to perioperative ARF, and the initial treatment once ARF develops.
After completing the module, the participant should be able to:
- Describe the definitions, epidemiology, and risk factors for the development of perioperative acute renal failure (ARF).
- Explain the workup and tests that will help establish the etiology of hospital-acquired ARF.
- Analyze the evidence for medical ARF risk reduction therapies.
- Identify medications commonly implicated in causing ARF among inpatients and how to prevent ARF from these medications.
- Describe preventive measures than can be taken to avoid contrast-induced nephropathy.
- Explain the presenting features and management of acute interstitial nephritis in the hospitalized patient.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: September 30, 2008. Expiration date: September 30, 2012.
*Instructor, Harvard Medical School, Associate Physician, Brigham and Women’s Hospital, Boston, Massachusetts.
†Associate Professor, Harvard Medical School, Medical Director, Brigham and Women’s/Faulkner Hospitalist Service, Boston, Massachusetts.
Disclaimer: The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Supported by an educational grant from Merck & Co., Inc.
Print
Email
Bookmark us!